Insider · CIK 0001205362
C Eric Winzer
Files at AURX (Nuo Therapeutics, Inc.). First filing -, latest -.
In brief
C Eric Winzer files SEC Form 4 as director at AURX (Nuo Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; C Eric Winzer has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | AURX Nuo Therapeutics, Inc. | MOption exercise Common Stock | +40,000 | $1.00 | $40k | 212,654 | Jul 2, 2026 |
| Jun 30, 2026 | AURX Nuo Therapeutics, Inc. | FTax withholding Common Stock | -39,604 | $1.01 | $40k | 173,050 | Jul 2, 2026 |
| Jun 30, 2026 | AURX Nuo Therapeutics, Inc. | MOption exercise Option to purchase common stockderivative | -40,000 | $0.00 | $0 | 0 | Jul 2, 2026 |
| Jun 29, 2026 | AURX Nuo Therapeutics, Inc. | AGrant or award Option to purchase common stockderivative | +30,000 | $0.00 | $0 | 30,000 | Jul 2, 2026 |
| Dec 17, 2025 | AURX Nuo Therapeutics, Inc. | MOption exercise Common Stock | +68,750 | $0.40 | $28k | 186,404 | Dec 22, 2025 |
| Dec 17, 2025 | AURX Nuo Therapeutics, Inc. | FTax withholding Common Stock | -13,750 | $2.00 | $28k | 172,654 | Dec 22, 2025 |
| Dec 31, 2025 | AURX Nuo Therapeutics, Inc. | MOption exercise Option to purchase common stockderivative | -68,750 | $0.00 | $0 | 0 | Dec 22, 2025 |
| Aug 1, 2025 | AURX Nuo Therapeutics, Inc. | MOption exercise Common Stock | +120,313 | $0.40 | $48k | 145,313 | Aug 4, 2025 |
| Aug 1, 2025 | AURX Nuo Therapeutics, Inc. | MOption exercise Common Stock | +120,313 | $0.40 | $48k | 145,313 | Aug 4, 2025 |
| Aug 1, 2025 | AURX Nuo Therapeutics, Inc. | FTax withholding Common Stock | -27,659 | $1.74 | $48k | 117,654 | Aug 4, 2025 |
| Aug 1, 2025 | AURX Nuo Therapeutics, Inc. | FTax withholding Common Stock | -27,659 | $1.74 | $48k | 117,654 | Aug 4, 2025 |
| Aug 9, 2018 | AURX Nuo Therapeutics, Inc. | MOption exercise Option to purchase common stockderivative | -120,313 | $0.00 | $0 | 0 | Aug 4, 2025 |
| Aug 9, 2018 | AURX Nuo Therapeutics, Inc. | MOption exercise Option to purchase common stockderivative | -120,313 | $0.00 | $0 | 0 | Aug 4, 2025 |
Questions about C Eric Winzer
Answered from the filings on this page, as of the latest one.
Is C Eric Winzer buying or selling?
C Eric Winzer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did C Eric Winzer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and C Eric Winzer has 0.
Where does C Eric Winzer file Form 4?
C Eric Winzer has filed Form 4 at AURX (Nuo Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.